US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
OmerDecugis & Cie (ALODC) 銘柄情報

OmerDecugis & Cie (ALODC)

8.20

0.24

(3.02%)

終了 6月8日 12:30AM

OmerDecugis & Cie (ALODC) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

8.20

( 3.02% )

買値

7.94

売値

8.20

出来高

13,463

8.04 日の範囲 8.32

5.22 52 週間の範囲 10.25

時価総額

前日終値

7.96

始値

8.04

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

4,335 €

発行済株式数

8,491,820

配当利回り

0.18 (2.00%)

PER

10.5

1 株当たり利益 (EPS)

0.74

歳入

284.88M

純利益

6.31M

Omer-Decugis & Cie SA produces and sells fresh fruits and vegetables in France and internationally. It offers bananas, pineapples, and mango and ripened fruits, as well as various exotic and ethnic, and premium fruits and vegetables. The company also provides tomatoes, apples, citrus fruits, beans, ... Omer-Decugis & Cie SA produces and sells fresh fruits and vegetables in France and internationally. It offers bananas, pineapples, and mango and ripened fruits, as well as various exotic and ethnic, and premium fruits and vegetables. The company also provides tomatoes, apples, citrus fruits, beans, pears, and seasonal fruits and vegetables. It offers its products under the Dibra, Terrasol, Selvatica, Le Marche, Don Ed’s, Fine, Elit, and Croq'apy brand names. The company was founded in 1850 and is based in Rungis, France. Omer-Decugis & Cie SA is a subsidiary of Lescot SAS. 詳細を表示

セクター

Consumer Staples

業界

Retailers - Staples

ウェブサイト

www.omerdecugis.com

本社

Rungis, France

設立

2026

OmerDecugis & Cie is listed in the Consumer Staples sector of the ユーロネクスト with ticker ALODC. The last closing price for OmerDecugis & Cie was 7.96 €. Over the last year, OmerDecugis & Cie shares have traded in a share price range of 5.22 € to 10.25 €.

OmerDecugis & Cie currently has 8,491,820 shares in issue. The market capitalisation of OmerDecugis & Cie is 69.63 € million. OmerDecugis & Cie has a price to earnings ratio (PE ratio) of 10.50.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.14	-1.67865707434	8.34	8.44	7.58	10591	8.09259725	DE
4	-0.6	-6.81818181818	8.8	8.8	7.58	5119	8.21128627	DE
12	-1.48	-15.2892561983	9.68	9.68	7.58	4609	8.68354437	DE
26	0.8	10.8108108108	7.4	10.25	7.12	8619	8.86174939	DE
52	2.64	47.4820143885	5.56	10.25	5.22	8011	8.20025713	DE
156	3.5	74.4680851064	4.7	10.25	3.65	5977	5.80593411	DE
260	0.7	9.33333333333	7.5	10.46	3.4	4409	6.1667732	DE

ALODC - Frequently Asked Questions (FAQ)

What is the current OmerDecugis & Cie share price?

The current share price of OmerDecugis & Cie is 8.20 €

How many OmerDecugis & Cie shares are in issue?

OmerDecugis & Cie has 8,491,820 shares in issue

What is the market cap of OmerDecugis & Cie?

The market capitalisation of OmerDecugis & Cie is EUR 69.63M

What is the 1 year trading range for OmerDecugis & Cie share price?

OmerDecugis & Cie has traded in the range of 5.22 € to 10.25 € during the past year

What is the PE ratio of OmerDecugis & Cie?

The price to earnings ratio of OmerDecugis & Cie is 10.5

What is the cash to sales ratio of OmerDecugis & Cie?

The cash to sales ratio of OmerDecugis & Cie is 0.23

What is the registered address of OmerDecugis & Cie?

The registered address for OmerDecugis & Cie is 1 Place Paul Omer-Decugis, Rungis, Ile-de-France, 94538

What is the OmerDecugis & Cie website address?

The website address for OmerDecugis & Cie is www.omerdecugis.com

Which industry sector does OmerDecugis & Cie operate in?

OmerDecugis & Cie operates in the Retailers - Staples sector

Eli's Gone

Eli's Gone 2分前

flipper44

flipper44 2分前

Apparently George doesn’t know the difference between EAG and CHM.

Sims1212

Sims1212 3分前

Ya ya good idea,keep buying this Scam.Chukkky remember the counter says its doubling in price in about 2 months lol

Major Profits

Major Profits 4分前

"Divy was an OTC ploy to get buyers. "
Methinks that is correct. NSAV did that in 2017.

https://www.globenewswire.com/news-release/2017/04/24/1087928/0/en/NSAV-Announces-10-Stock-Dividend-and-June-1-Record-Date.html
NSAV Announces 10% Stock Dividend and June 1 Record Dat

flipper44

flipper44 6分前

Stonkmaster just talked to him around June 2nd or 3rd.

SemperFITrader

SemperFITrader 7分前

Krisgo, I did get a follow up from GZ after the email from MHRA, I sent to GZ and DI my email from MHRA.

"Thank you for clarifying for your investor peers what we've pretty much been telling everyone all along: the CHM just provides advice, it does not make decisions

jimr1717

jimr1717 8分前

Has the merger with Wertheim been completed? Lmao

BIOChecker4

BIOChecker4 9分前

You are literally the only person left who believes that (or pretends to).

Boat Shoes Warrior

Boat Shoes Warrior 11分前

Does anyone know what happened to the Secret Plan?
(Asking for a friend)

pos_stock_hoarder

pos_stock_hoarder 12分前

https://featureassets.gocomics.com/assets/0a63ee302714013fc072005056a9545d?optimizer=image&width=1200&quality=85

pos_stock_hoarder

pos_stock_hoarder 12分前

https://featureassets.gocomics.com/assets/0a63ee302714013fc072005056a9545d?optimizer=image&width=1200&quality=85

NorthPeak22

NorthPeak22 13分前

I'll tell you exactly why I tend to trust their analysis. They recommended Voyager Digital at ~.50 when they signed a marketing contract with them. The stock then went to ~$30 over the next 1.5-2 years. Voyager offered another contract and the NIA refused bc of what they saw in their most recent fin

TightCoil

TightCoil 13分前

With LunarD on our side, we Fly tomorrow

Vexari

Vexari 13分前

Krombacher

Krombacher 16分前

Johnydollar.

You're absolutely right that DBMM is fighting organically. And I respect that framing. But here's the reality that organic growth runs into every single time:

Growth requires capital. Capital requires a share price that makes fundraising viable. And a share

DAR53

No, patent approval (or notification) is expected before EOY 26. I think it's generally been a 31/2 - 4 year process and that began January 2023 for US. So we're 3 1/2 years and counting. Of course when / if patent approval, we will still need FDA approval but hopes are that it will be more quic

peafunke

peafunke 20分前

What does that have to do with where they are and what they are doing? Why do they need to be out of EM ?
It makes a LOT of sense why they are still in EM.

bigstocksnbonds

bigstocksnbonds 22分前

Hard worker good you mowed and saw mom get rested!

NorthPeak22

NorthPeak22 24分前

So you have a problem with their analysis? What specifically in what I posted do you find laughable or simply not possible? I don't do the whole fallacy thing.

speakhim

speakhim 25分前

I thought you only worked Monday through Friday

vas2

Is n't full patent approval 12-24 months away? Best we can hope for is notice of allowance by end of the year.

DAR53

I agree. Still waiting to hear anything good regarding Amarin's direction and future. The old saying 'can't win for losing' certainly applies to Amarin. So, the LR patent, positive EMT2 as well as Recordati and Edding in China are the things we can hold to for now.

PIPEYARD HERO

PIPEYARD HERO 27分前

OK, let me be more direct. Speaking for myself, I couldn't in good faith post anything from NIA. I wouldn't trust it as evidence of anything other than proof there's a lot of garbage peddled on the internet. I fail to see how citing NIA strengthens any argument or serves any purpose other than as

jour_trader

jour_trader 27分前

When you combine revenues for full year 2025 from Bristol Meyer & Pfizer (joint distribution agreement), we get: $5.1B for Pfizer and $10.2B for Bristol Meyer.
That gives us roughly $15B total transfer market today. About double my initial estimate and roughly half of what IQVIA states from y

OmerDecugis & Cie

Odawara Engineering (PK)

Pharmaceutical Product Developme

Cvr Energy Inc Dl 01

Atlas Global Brands

3.960% Nts 15/03/38

Stellus Capital Investment

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。